McLaren Northern Michigan has been chosen as the winner of ECRI's 16th Health Technology Excellence Award for seamless integration of cutting-edge patient care technologies utilized in their newly built hospital addition. MEDI+SIGN is proud to have played a key role in this groundbreaking project.
SMITHSBURG, Md., July 20, 2022 /PRNewswire-PRWeb/ -- McLaren Northern Michigan has been chosen as the winner of ECRI's 16th Health Technology Excellence Award for seamless integration of cutting-edge patient care technologies utilized in their newly built hospital addition. MEDI+SIGN is proud to have played a key role in this groundbreaking project.
For more than five decades ECRI has utilized an unbiased, evidence-based approach to protect patients from unsafe and ineffective medical technologies and practices. The Health Technology Excellence Award is presented each year from ECRI to recognize innovative and effective initiatives undertaken by healthcare institutions to improve patient safety, reduce costs, or otherwise facilitate better strategic management of health technology. ECRI received award entries from hospitals in the United States, as well as internationally, including from Columbia, India, Pakistan, New Zealand, and Canada.
McLaren's award-winning submission described the regional hospital's expansion plan to build 200 private patient rooms and a range of clinical care areas. In addition to the new physical spaces, the focus of the project was to build the safest and most advanced integrated patient experience, requiring several leading technology and communications companies to work together. Bridging key systems central to patient monitoring and safety, staff communications, electronic medical record access, as well as Internet Protocol television (IPTV) and entertainment together under one easy-to-use system is a very unique, complex vision that requires the right team willing to collaborate. All parties understood the importance and value of teamwork required to bring this truly unique, all inclusive technological system to fruition with an ultimate goal of keeping patients safe.
"The vision of deeper system integration between vendors had the potential to change how patients, their families, as well as clinical staff could have the best hospital experience possible," said David Linetsky, MEDI+SIGN Founder and CEO. "From the inception of MEDI+SIGN, we have been leading the industry in hospital patient room technology, continuously improving our products with the ultimate goal of making hospitals safer. When you can not only improve your business structure but also collaborate and challenge yourself and your partners to push their products and services forward, all while improving the way hospitals operate, it's inspiring."
MEDI+SIGN continues to optimize integrations with technology partners involved in this project, identifying opportunities for strategic improvements and ensuring the technology stays ahead of the medical industry and McLaren Northern Michigan's growth.
MEDI+SIGN is a game-changing communication tool used by hospitals that are pursuing the creation, improvement, and sustainability of their quality and safety goals. Driven and perfected by evidence-based outcomes, MEDI+SIGN deploys strategies tailored to the hospital's specific needs and existing workflows. This unique approach allows hospitals to experience quality and safety transformations without negatively impacting the day-to-day workflow of staff. MEDI+SIGN is the first and only patient-facing technology in its class that requires zero effort from clinical staff while reinvesting time back to the bedside. With patient experience and complex psychology at the epicenter of this technology, patients are kept informed, satisfied, and safe. Beyond patient experience, MEDI+SIGN focuses on improving HCAHPS and increasing patient safety by preventing falls as well as other sentinel events related to HAC, among other CMS programs. To experience these results for yourself, visit medisigndisplays.com.
About McLaren Northern Michigan
McLaren Northern Michigan is a 202-bed regional hospital located in Petoskey, Michigan serving residents in 22 counties across northern Lower Michigan and the eastern part of the Upper Peninsula. More than 230 physicians represent nearly all medical and surgical specialties, enabling full-service care with an emphasis on cardiology, cancer, orthopedics, and neurosciences. McLaren Northern Michigan has a network of primary care providers and specialty care clinics throughout the region, and an outpatient surgery center in Cheboygan. It has achieved Magnet® status for nursing excellence, been named a Top 50 heart hospital in the U.S. by IBM/Watson Health, and received the highest national ratings from the Centers for Medicare and Medicaid Services for quality and safety.
About McLaren Health Care
McLaren Health Care, headquartered in Grand Blanc, Michigan, is a $6 billion, fully integrated health care delivery system committed to quality, evidence-based patient care and cost efficiency. The McLaren system includes 15 hospitals in Michigan and Ohio, ambulatory surgery centers, imaging centers, a 490-member employed primary and specialty care physician network, commercial and Medicaid HMOs covering more than 588,000 lives in Michigan and Indiana, home health, infusion and hospice providers, pharmacy services, a clinical laboratory network and a wholly owned medical malpractice insurance company. McLaren operates Michigan's largest network of cancer centers and providers, anchored by the Karmanos Cancer Institute, one of only 51 National Cancer Institute-designated comprehensive cancer centers in the U.S. McLaren has 28,000 full-, part-time and contracted employees and more than 90,000 network providers throughout Michigan, Indiana and Ohio. Learn more at mclaren.org.
ECRI is an independent, nonprofit organization improving the safety, quality, and cost-effectiveness of care across all healthcare settings. With a focus on health technology and safety solutions, ECRI is respected and trusted by healthcare leaders and agencies worldwide. Over more than fifty years, ECRI has built its reputation on integrity and disciplined rigor, with an unwavering commitment to independence and strict conflict-of-interest rules. ECRI is the only organization worldwide to conduct independent medical device evaluations, with labs located in North America and Asia Pacific. ECRI is designated an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality. ECRI and the Institute for Safe Medication Practices PSO is a federally certified Patient Safety Organization as designated by the U.S. Department of Health and Human Services. The Institute for Safe Medication Practices (ISMP) formally became an ECRI Affiliate in 2020. Visit ecri.org and follow @ECRI_Org.
MEDI+SIGN is a registered trademark. © 2022 MEDI+SIGN® All Rights Reserved
ECRI. Integrating patient-centric technologies to improve care and enhance the patient experience—McLaren Northern Michigan's award-winning initiative. Device Evaluation 2022 May 4. Read the full article here.
John Silipino, MEDI+SIGN, 301-790-0103, [email protected]